Frontal Fibrosing Alopecia: Update on Treatment 2025

The presentation discusses advancements in the treatment of Frontal Fibrosing Alopecia (FFA), emphasizing personalized approaches based on patient demographics and health status. It highlights the significance of managing patient expectations, primarily focusing on stabilizing the condition rather than promising improvements. Various treatment options are divided by disease phases: early interventions may include 5-alpha reductase inhibitors to prevent inflammation, while established inflammation might require anti-inflammatory treatments like hydroxychloroquine or topical calcineurin inhibitors. Novel therapies such as dutasteride have shown promise, achieving stabilization in a significant percentage of patients. Other treatments mentioned include oral minoxidil for hair density, PRP for skin improvement, and various options for aesthetic enhancement, such as scalp micro pigmentation and wigs. The importance of continuous evaluation and adaptation of treatment protocols, as well as staying updated on new therapies, is emphasized. Current therapeutic recommendations involve a combination of topical treatments, oral medications, and cosmetic procedures to enhance patients' quality of life. The discussion concludes with optimism for future research and potential breakthroughs in treating FFA.